These data indicated that, in accordance with the hypothesis of the existence of a prostaglandin E2-dependent negative feedback inhibition loop, the enhanced capacity for PGE2 production in NASH patients might reduce TNF-α expression. The gene discussed is TNF; the disease is metabolic dysfunction-associated steatohepatitis.